4Filed Jun 30, 8:00 PM ET

Pharvaris (PHVS) Director Schikan Sells 37,600 Shares

$PHVS · Pharvaris N.V.

Research Summary

AI-generated summary of this SEC filing

Updated

Pharvaris (PHVS) Director Schikan Sells 37,600 Shares

What Happened

  • Schikan Johannes Gerardus Christiaan Petrus, a director of Pharvaris N.V. (PHVS), sold a total of 37,600 shares in two open-market transactions: 6,888 shares on 2026-06-29 at an average price of $35.05 for $241,447, and 30,712 shares on 2026-06-30 at an average price of $35.49 for $1,090,049. Total proceeds were approximately $1,331,496. These were sales (not purchases), which are often routine dispositions by insiders.

Key Details

  • Transaction dates and prices:
    • 2026-06-29: 6,888 shares at $35.05 — $241,447 (per-footnote: weighted avg price; trades ranged $35.00–$35.10)
    • 2026-06-30: 30,712 shares at $35.49 — $1,090,049 (per-footnote: weighted avg price; trades ranged $35.00–$35.90)
  • Total shares sold: 37,600; total proceeds ≈ $1,331,496.
  • Footnotes: Sales executed pursuant to a Rule 10b5-1 trading plan (scheduled sales). Weighted-average prices reported; filer offers to disclose per‑trade breakouts on request.
  • Shares owned after the transactions: Not specified in the provided filing summary.
  • Filing status: Form 4 filed 2026-07-01 for transactions on 2026-06-29 and 2026-06-30 — appears to be timely.

Context

  • A Rule 10b5-1 plan lets insiders pre-schedule trades and is commonly used to avoid timing concerns; scheduled sales under such plans do not necessarily indicate a change in view about the company. Sales are informative about liquidity but purchases typically carry stronger signals about insider confidence.